{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02023411","recordId":"NCT02023411","peptideSlug":"teriparatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02023411-teriparatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02023411.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02023411.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2013-12-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"teriparatide","submittedDate":"2013-12-23","publishedAt":"2026-08-23","recordId":"NCT02023411","recordSha256":"4354c9451ee4ba13f28b5750e12b389a72997220fb82b50b543cb537e577eeb9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02023411?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Contacts/Locations","Document Section","Limitations and Caveats","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-08-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"teriparatide","submittedDate":"2020-08-25","publishedAt":"2026-08-23","recordId":"NCT02023411","recordSha256":"57b1f4d66dd49b4a0b6dd270dd43ac5e2eef79b10ba89dc50302e4e0f8810867","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02023411?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Limitations and Caveats","Participant Flow","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2021-06-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"teriparatide","submittedDate":"2021-06-28","publishedAt":"2026-08-23","recordId":"NCT02023411","recordSha256":"0c0aa5c7152ec6ed0770c83d6c882adfda629bcb476bdce204fd2eb3ffd94a00","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02023411?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"90bf00125d4d6d8c3f3fe93acfa40b6ecf8cef33a9f1a0e3489ae0b9ad955c9a"}}